HSPA9 and malignant colon neoplasm: Finally, to understand the contribution of mot-2 to the anti-cancer mechanism of VTD, we used a mot-2 inhibitor known as MKT-077 [7] along with VTD in well-differentiated SW-48 (WT-p53) colon cancer cells for 72 hours.